Literature DB >> 6195335

Cross-reactivity of vector-borne metacyclic forms of Trypanosoma cruzi with mammalian and culture stages.

F Villalta, F Kierszenbaum.   

Abstract

Metacyclic forms of Trypanosoma cruzi isolated from the hindgut of infected insect vectors (Rhodnius prolixus) were found to be immunologically cross-reactive with cultured epimastigote, amastigote, and metacyclic stages of the parasite as well as with bloodstream trypomastigote forms by direct agglutination and indirect immunofluorescence techniques. Sera specific for each of these forms of the parasite systematically yielded maximal antibody titers when measured against the homologous antigen, indicating that antigenic determinants are shared by all of the developmental forms used in this work. Supporting this conclusion were the significant reductions in anti-insect-derived metacyclic antibody titer caused by absorption with any of the other life stages of T. cruzi. These results are relevant to the potential use of laboratory-grown forms of T. cruzi in vaccination against a natural infection with this parasite.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195335     DOI: 10.1111/j.1550-7408.1983.tb02924.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  3 in total

1.  Trypanosoma cruzi glycoprotein 72: immunological analysis and cellular localization.

Authors:  G Harth; A A Mills; T Souto-Padrón; W de Souza
Journal:  Mol Cell Biochem       Date:  1992-01-15       Impact factor: 3.396

2.  Purification of a Trypanosoma cruzi trypomastigote 60-kilodalton surface glycoprotein that primes and activates murine lymphocytes.

Authors:  F Villalta; M F Lima; S A Howard; L Zhou; A Ruiz-Ruano
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Neuraminidase from Trypanosoma cruzi: analysis of enhanced expression of the enzyme in infectious forms.

Authors:  G Harth; C G Haidaris; M So
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.